Provost David A
Division of Gastrointestinal and Endocrine Surgery, Department of Surgery, The University of Texas Southwestern Medical Center at Dallas, TX 75039, USA.
Surg Clin North Am. 2005 Aug;85(4):789-805, vii. doi: 10.1016/j.suc.2005.04.004.
Bariatric surgery is the only effective treatment producing sustained weight loss and reduction in comorbidities in the morbidly obese. Laparoscopic adjustable gastric banding (LAGB) has evolved considerably in techniques of insertion and band management since the initial descriptions in the early 1990s. Major advantages of LAGB include lower perioperative morbidity and mortality, adjust-ability, and reversibility. Although weight loss occurs more slowly than after gastric bypass, end results are comparable.
减重手术是唯一能使病态肥胖患者持续减重并降低合并症的有效治疗方法。自20世纪90年代初首次描述以来，腹腔镜可调节胃束带术（LAGB）在植入技术和束带管理方面有了很大发展。LAGB的主要优点包括围手术期发病率和死亡率较低、可调节性和可逆性。虽然体重减轻比胃旁路术后发生得更慢，但最终结果相当。
